Virtual Medicinal Product (VMP) - Terazosin 5mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Terazosin 5mg tablets Start Date 15-12-2002 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
G04CA03
BNF Start Date End Date
Current BNF 02050400 Start Date 04-04-2022 End Date
Previous BNF 02050400 Start Date 07-02-2005 End Date 03-04-2022
Previous BNF 07040100 Start Date 07-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
42043211000001107 07-07-2023
318776005 15-12-2002 06-07-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Terazosin hydrochloride Based on Base Substance Terazosin 5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
7 tablet
28 tablet 469 Part VIIIA Category A
30 tablet